A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 528,421 shares of TMO stock, worth $316 Million. This represents 2.79% of its overall portfolio holdings.

Number of Shares
528,421
Previous 527,535 0.17%
Holding current value
$316 Million
Previous $307 Million 4.69%
% of portfolio
2.79%
Previous 2.94%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$541.52 - $599.02 $479,786 - $530,731
886 Added 0.17%
528,421 $292 Million
Q1 2024

Apr 23, 2024

SELL
$528.82 - $599.43 $3.91 Million - $4.43 Million
-7,386 Reduced 1.38%
527,535 $307 Million
Q4 2023

Feb 01, 2024

SELL
$431.41 - $532.94 $489,650 - $604,886
-1,135 Reduced 0.21%
534,921 $284 Million
Q3 2023

Nov 03, 2023

BUY
$498.29 - $574.41 $3.6 Million - $4.15 Million
7,230 Added 1.37%
536,056 $271 Million
Q2 2023

Aug 01, 2023

BUY
$508.46 - $591.13 $4.55 Million - $5.29 Million
8,943 Added 1.72%
528,826 $276 Million
Q1 2023

May 02, 2023

BUY
$535.0 - $604.82 $422,115 - $477,202
789 Added 0.15%
519,883 $300 Million
Q4 2022

Mar 02, 2023

SELL
$484.71 - $571.37 $350,445 - $413,100
-723 Reduced 0.14%
519,094 $286 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $2.13 Million - $2.51 Million
4,398 Added 0.85%
519,817 $314 Million
Q3 2022

Oct 25, 2022

BUY
$507.19 - $604.49 $3.95 Million - $4.71 Million
7,793 Added 1.54%
515,419 $261 Million
Q2 2022

Jul 26, 2022

BUY
$500.9 - $612.21 $3.35 Million - $4.1 Million
6,697 Added 1.34%
507,626 $276 Million
Q1 2022

Apr 13, 2022

BUY
$524.0 - $644.92 $2.42 Million - $2.98 Million
4,619 Added 0.93%
500,929 $296 Million
Q4 2021

Feb 14, 2022

BUY
$569.0 - $667.24 $9.02 Million - $10.6 Million
15,855 Added 3.3%
496,310 $331 Million
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $30.7 Million - $36.8 Million
60,289 Added 14.35%
480,455 $274 Million
Q2 2021

Aug 13, 2021

BUY
$441.0 - $508.24 $33.5 Million - $38.6 Million
75,916 Added 22.05%
420,166 $212 Million
Q1 2021

Apr 14, 2021

BUY
$439.85 - $518.83 $43.9 Million - $51.8 Million
99,898 Added 40.88%
344,250 $157 Million
Q4 2020

Jan 14, 2021

BUY
$435.06 - $527.66 $9.74 Million - $11.8 Million
22,396 Added 10.09%
244,352 $114 Million
Q3 2020

Oct 15, 2020

BUY
$359.77 - $441.52 $546,130 - $670,227
1,518 Added 0.69%
221,956 $98 Million
Q2 2020

Jul 30, 2020

SELL
$275.2 - $362.34 $330,515 - $435,170
-1,201 Reduced 0.54%
220,438 $79.9 Million
Q1 2020

Apr 15, 2020

SELL
$255.3 - $340.05 $66,378 - $88,413
-260 Reduced 0.12%
221,639 $62.9 Million
Q4 2019

Jan 22, 2020

SELL
$271.93 - $328.04 $13,868 - $16,730
-51 Reduced 0.02%
221,899 $72.1 Million
Q3 2019

Nov 05, 2019

BUY
$268.46 - $305.43 $628,464 - $715,011
2,341 Added 1.07%
221,950 $64.6 Million
Q2 2019

Aug 09, 2019

BUY
$257.51 - $295.55 $212,188 - $243,533
824 Added 0.38%
219,609 $64.5 Million
Q1 2019

Apr 08, 2019

SELL
$212.17 - $273.72 $164,643 - $212,406
-776 Reduced 0.35%
218,785 $59.9 Million
Q4 2018

Feb 13, 2019

BUY
$208.47 - $251.98 $1.88 Million - $2.27 Million
8,997 Added 4.27%
219,561 $49.1 Million
Q3 2018

Oct 31, 2018

BUY
$205.57 - $244.32 $2 Million - $2.38 Million
9,739 Added 4.85%
210,564 $51.4 Million
Q2 2018

Aug 07, 2018

BUY
$203.14 - $219.53 $1.02 Million - $1.11 Million
5,037 Added 2.57%
200,825 $41.6 Million
Q1 2018

Apr 20, 2018

BUY
$192.98 - $224.11 $714,990 - $830,327
3,705 Added 1.93%
195,788 $40.4 Million
Q4 2017

Feb 08, 2018

BUY
$182.03 - $200.37 $464,904 - $511,744
2,554 Added 1.35%
192,083 $36.5 Million
Q3 2017

Oct 27, 2017

BUY
$171.74 - $194.04 $504,915 - $570,477
2,940 Added 1.58%
189,529 $35.9 Million
Q2 2017

Aug 07, 2017

BUY
N/A
186,589
186,589 $0

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $235B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.